Indrayani Biotech has disclosed the resignation of its secretarial auditor, K. Ravichandran. The departure becomes effective from August 6, 2026.

The company informed the Bombay Stock Exchange on September 7, 2026, regarding the change in statutory personnel. Mr. Ravichandran cited personal reasons for stepping down from his role.

Regulatory Disclosure

The notification was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure aligns with Part A of Schedule III to the regulations and applicable SEBI circulars.

Mr. Ravichandran holds Membership No. ACS12838 and Certificate of Practice No. 3207. The filing includes a copy of his resignation letter and detailed disclosures as required by the listing norms.

Next Steps

The Audit Committee and the Board of Directors will consider the appointment of a new secretarial auditor to fill the vacancy. The company stated that the appointment will be made in due course and intimated to the exchanges accordingly.

Swaminathan Govindarajan, Whole-time Director, signed the disclosure letter.

Indrayani Biotech Limited has secured a two-month extension from the Registrar of Companies (ROC), Chennai, to hold its 34th Annual General Meeting (AGM) for FY26. The new deadline is November 30, 2026.

The company applied for the extension under Section 96(1) of the Companies Act, 2013, citing the need to plan a capital restructuring that includes a rights issue. This process requires multiple statutory and regulatory approvals, preventing the timely convening of the meeting.

Regulatory Timeline

The original deadline for holding the AGM was September 30, 2026, as per standard requirements for the financial year ended March 31, 2026. The ROC approved the extension vide SRN AC5569272 on September 4, 2026.

Corporate Governance

The Board of Directors will finalize the exact date of the AGM within the extended timeline and communicate it to the stock exchanges in due course. Swaminathan Govindarajan, Whole-time Director, signed the intimation filed with BSE Limited under Regulation 30 of SEBI (LODR) Regulations, 2015.

The ROC advised the company to ensure careful compliance with the Companies Act provisions in future filings.